Literature DB >> 15578903

Low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate.

Adriana Reyes1, Cesar A Moran.   

Abstract

A case of primary, prostatic, low-grade neuroendocrine carcinoma (carcinoid tumor) is described. The patient is an 86-year-old man who presented with symptoms of gross hematuria of several days' duration. Physical examination and a bladder biopsy specimen revealed the presence of a primary adenocarcinoma of the bladder with invasion into the muscularis propria. A cystoprostatectomy was performed, which revealed the presence of invasive adenocarcinoma of the bladder. Prostatic sampling demonstrated the presence of a low-grade neuroendocrine carcinoma (carcinoid tumor) and a small focus of well-differentiated conventional adenocarcinoma. Immunohistochemical studies using neuroendocrine markers clearly demarcated the presence of the neuroendocrine tumor. The case presented herein highlights the ubiquitous distribution of neuroendocrine neoplasms along the male genitourinary tract and the presence of 3 separate neoplasms in the genitourinary tract.

Entities:  

Mesh:

Year:  2004        PMID: 15578903     DOI: 10.5858/2004-128-e166-LNCCTO

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  3 in total

1.  A pure primary low-grade neuroendocrine carcinoma (carcinoid tumor) of the prostate.

Authors:  Salvatore Giordano; Teemu Tolonen; Tuomo Tolonen; Susanna Hirsimäki; Vesa Kataja
Journal:  Int Urol Nephrol       Date:  2009-10-29       Impact factor: 2.370

2.  Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.

Authors:  Jonathan I Epstein; Mahul B Amin; Himisha Beltran; Tamara L Lotan; Juan-Miguel Mosquera; Victor E Reuter; Brian D Robinson; Patricia Troncoso; Mark A Rubin
Journal:  Am J Surg Pathol       Date:  2014-06       Impact factor: 6.394

3.  Review of small cell carcinomas of the prostate.

Authors:  P Furtado; M V A Lima; C Nogueira; M Franco; F Tavora
Journal:  Prostate Cancer       Date:  2011-08-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.